Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 49 results.
User Information
Export Records
  1. 1.   Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model
  2. Alsaidi, Sahar; Cornejal, Nadjet; Mahoney, Oneil; Melo, Claudia; Verma, Neeharika; Bonnaire, Thierry; Chang, Theresa; O'Keefe,Barry; Sailer, James; Zydowsky, Thomas M; Teleshova, Natalia; Romero, José A Fernández
  3. Marine drugs. 2021, Aug; 19(8):
  1. 2.   A frizzled-like cysteine rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice
  2. Li, Na; Wei, Liwen; Liu, Xiaoyu; Bai, Hongjun; Ye, Yvonne; Li, Dan; Li, Nan; Baxa,Ulrich; Wang, Qun; Lv, Ling; Chen, Yun; Feng, Mingqian; Lee, Byungkook; Gao, Wei; Ho, Mitchell
  3. Hepatology (Baltimore, Md.). 2019, OCT; 70(4): 1231-1245.
  1. 3.   Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity
  2. Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Jayanthi, Srinivas; Gundampati, Ravi Kumar; Su, Guowei; Bear,Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber,Barbara; Liu, Jian; Thallapuranam, Suresh Kumar; Zaharoff, David A.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2019, Mar 22; 294(12): 4412-4424.
  1. 4.   Ion quantification in liposomal drug products using high performance liquid chromatography
  2. Wu, Jiewei; Crist,Rachael; McNeil,Scott; Clogston,Jeffrey
  3. Journal of pharmaceutical and biomedical analysis. 2019, Feb 20; 165: 41-46.
  1. 5.   Crystal structure of the human dual specificity phosphatase 1 catalytic domain
  2. Gumpena, Rajesh; Lountos, George; Raran-Kurussi, Sreejith; Tropea, Joseph; Cherry, Scott; Waugh, David
  3. Protein science : a publication of the Protein Society. 2018, Feb; 27(2): 561-567.
  1. 6.   Modifications of Glycans: Biological Significance and Therapeutic Opportunities
  2. Muthana, S. M.; Campbell, C. T.; Gildersleeve, J. C.
  3. Acs Chemical Biology. 2012, Jan; 7(1): 31-43.
  1. 7.   Application of a Novel Score Test for Genetic Association Incorporating Gene-Gene Interaction Suggests Functionality for Prostate Cancer Susceptibility Regions
  2. Ciampa, J.; Yeager, M.; Jacobs, K.; Thun, M. J.; Gapstur, S.; Albanes, D.; Virtamo, J.; Weinstein, S. J.; Giovannucci, E.; Willett, W. C.; Cancel-Tassin, G.; Cussenot, O.; Valeri, A.; Hunter, D.; Hoover, R.; Thomas, G.; Chanock, S.; Holmes, C.; Chatterjee, N.
  3. Human Heredity. 2011, Nov; 72(3): 182-193.
  1. 8.   Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors
  2. Jones, K. S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F. W.; Hermine, O.; Pique, C.
  3. Viruses-Basel. 2011, Jun; 3(6): 794-810.
  1. 9.   Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes
  2. Zemskov, E. A.; Mikhailenko, I.; Hsia, R. C.; Zaritskaya, L.; Belkin, A. M.
  3. Plos One. 2011, Apr; 6(4): 14.
  1. 10.   Innate immune mechanisms of colitis and colitis-associated colorectal cancer
  2. Saleh, M.; Trinchieri, G.
  3. Nature Reviews Immunology. 2011, Jan; 11(1): 9-20.
  1. 11.   Interaction between the HTLV-I envelope and cellular proteins: impact on virus infection and restriction
  2. Ilinskaya, A.; Heidecker, G.; Jones, K.
  3. Future Medicinal Chemistry. 2010, Nov; 2(11): 1651-1668.
  1. 12.   Current concepts regarding the HTLV-1 receptor complex
  2. Ghez, D.; Lepelletier, Y.; Jones, K. S.; Pique, C.; Hermine, O.
  3. Retrovirology. 2010, Nov; 7: 11.
  1. 13.   Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium
  2. Canzian, F.; Cox, D. G.; Setiawan, V. W.; Stram, D. O.; Ziegler, R. G.; Dossus, L.; Beckmann, L.; Blanche, H.; Barricarte, A.; Berg, C. D.; Bingham, S.; Buring, J.; Buys, S. S.; Calle, E. E.; Chanock, S. J.; Clavel-Chapelon, F.; DeLancey, J. O. L.; Diver, W. R.; Dorronsoro, M.; Haiman, C. A.; Hallmans, G.; Hankinson, S. E.; Hunter, D. J.; Husing, A.; Isaacs, C.; Khaw, K. T.; Kolonel, L. N.; Kraft, P.; Le Marchand, L.; Lund, E.; Overvad, K.; Panico, S.; Peeters, P. H. M.; Pollak, M.; Thun, M. J.; Tjonnel, A.; Trichopoulos, D.; Tumino, R.; Yeager, M.; Hoover, R. N.; Riboli, E.; Thomas, G.; Henderson, B. E.; Kaaks, R.; Feigelson, H. S.
  3. Human Molecular Genetics. 2010, Oct; 19(19): 3873-3884.
  1. 14.   MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
  2. Salcedo, R.; Worschech, A.; Cardone, M.; Jones, Y.; Gyulai, Z.; Dai, R. M.; Wang, E. N.; Ma, W.; Haines, D.; O'HUigin, C.; Marincola, F. M.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2010, Aug 2; 207(8): 1625-1636.
  1. 15.   A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses
  2. Matsumoto, K.; Irie, F.; Mackem, S.; Yamaguchi, Y.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Jun; 107(24): 10932-10937.
  1. 16.   Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2010, May; 285(20): 15619-15626.
  1. 17.   Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
  2. Wang, S. S.; Gonzalez, P.; Yu, K.; Porras, C.; Li, Q. Z.; Safaeian, M.; Rodriguez, A. C.; Sherman, M. E.; Bratti, C.; Schiffman, M.; Wacholder, S.; Burk, R. D.; Herrero, R.; Chanock, S. J.; Hildesheim, A.
  3. Plos One. 2010, Jan; 5(1): 7.
  1. 18.   The Receptor Complex Associated with Human T-Cell Lymphotropic Virus Type 3 (HTLV-3) Env-Mediated Binding and Entry Is Distinct from, but Overlaps with, the Receptor Complexes of HTLV-1 and HTLV-2
  2. Jones, K. S.; Huang, Y. K.; Chevalier, S. A.; Afonso, P. V.; Petrow-Sadowski, C.; Bertolette, D. C.; Gessain, A.; Ruscetti, F. W.; Mahieux, R.
  3. Journal of Virology. 2009 83(10): 5244-5255.
  1. 19.   HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF(165)
  2. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F. W.; Perret, G.; Jones, K. S.; Pique, C.
  3. Blood. 2009 113(21): 5176-5185.
  1. 20.   GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1
  2. Takenouchi, N.; Jones, K. S.; Lisinski, I.; Fugo, K.; Yao, K.; Cushman, S. W.; Ruscetti, F. W.; Jacobson, S.
  3. Journal of Virology. 2007, Feb; 81(3): 1506-1510.
  1. 21.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
  1. 22.   Critical design features of phenyl carboxylate-containing polymer microbicides
  2. Rando, R. F.; Obara, S.; Osterling, M. C.; Mankowski, M.; Miller, S. R.; Ferguson, M. L.; Krebs, F. C.; Wigdahl, B.; Labib, M.; Kokub, H.
  3. Antimicrobial Agents and Chemotherapy. 2006, Sep; 50(9): 3081-3089.
  1. 23.   Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation
  2. Vaillant, A.; Juteau, J. M.; Lu, H.; Liu, S. W.; Lackman-Smith, C.; Ptak, R.; Jiang, S. B.
  3. Antimicrobial Agents and Chemotherapy. 2006, Apr; 50(4): 1393-1401.
  1. 24.   In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories
  2. Beer, B. E.; Doncel, G. F.; Krebs, F. C.; Shattock, R. J.; Fletcher, P. S.; Buckheit, R. W.; Watson, K.; Dezzutti, C. S.; Cummins, J. E.; Bromley, E.; Richardson-Harman, N.; Pallansch, L. A.; Lackman-Smith, C.; Osterling, C.; Mankowski, M.; Miller, S. R.; Catalone, B. J.; Welsh, P. A.; Howett, M. K.; Wigdahl, B.; Turpin, J. A.; Reichelderfer, P.
  3. Antimicrobial Agents and Chemotherapy. 2006, Feb; 50(2): 713-723.
  1. 25.   Species-specific effects of the hepatocarcinogens 3 '-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver
  2. Merkulova, T. I.; Kropachev, K. Y.; Timofeeva, O. A.; Vasiliev, G. V.; Levashova, Z. B.; Ilnitskaya, S. I.; Kobzev, V. F.; Pakharukova, M. Y.; Bryzgalov, L. O.; Kaledin, V. I.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 223-232.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel